Viking Global Opportunities Illiquid Investments Sub-Master LP

10% owner at RayzeBio, Inc. · on record since Sep 21, 2023
10% owner at LABRANCHE & CO INC · on record since Mar 20, 2024
10% owner at APi Group Corp · on record since Mar 7, 2024
10% owner at Sio Gene Therapies Inc. · on record since Jul 13, 2016
10% owner at Arbutus Biopharma Corp · on record since Jul 13, 2016
10% owner at Glori Energy Inc. · on record since Jun 7, 2024
10% owner at TIC Solutions, Inc. · on record since Feb 14, 2025
10% owner at Myovant Sciences Ltd. · on record since Oct 26, 2016
Former 10% Owner at Editas Medicine, Inc. · on record since Feb 9, 2016
10% owner at Editas Medicine, Inc. · on record since Feb 8, 2016
10% owner at FIGS, Inc. · on record since Jun 7, 2021
10% owner at GENENTECH INC · on record since Sep 23, 2021
10% owner at Urovant Sciences Ltd. · on record since Sep 26, 2018
10% owner at BridgeBio Pharma, Inc. · on record since Jun 28, 2019
10% owner at Steel Excel Inc. · on record since Jun 26, 2019
Former 10% Owner at Urovant Sciences Ltd. · on record since Jul 12, 2019
Former 10% Owner at Arbutus Biopharma Corp · on record since Jul 12, 2019
Former 10% Owner at · on record since Jul 12, 2019
10% owner at · on record since Apr 28, 2020
10% owner at · on record since Apr 8, 2020
10% owner at · on record since Aug 28, 2020
10% owner at · on record since Jul 29, 2021
10% owner at · on record since Dec 17, 2020
10% owner at · on record since Sep 21, 2021
10% owner at · on record since Oct 1, 2021
10% owner at · on record since Jan 13, 2022
10% owner at · on record since Nov 25, 2022

Insider trading activity of Viking Global Opportunities Illiquid Investments Sub-Master LP

Transactions on record: 36; since Dec 20, 2018

Open-market buys: 13; $87.9M

Open-market sells: 20; $263.3M

Companies traded: 9; last filing Jan 31, 2025

Figures computed from official regulatory filings — .

Companies where Viking Global Opportunities Illiquid Investments Sub-Master LP has traded

1 tx · $107M · Jan 31, 2025
2 tx · $104.1M · Mar 7, 2024
1 tx · $10.5M · Jan 5, 2024
18 tx · $85.4M · Sep 9, 2022
3 tx · $10.5M · Aug 2, 2021
2 tx · $3.4M · Aug 28, 2020
1 tx · $20M · Jun 13, 2019
7 tx · $328.9K · Jun 6, 2019
1 tx · $10M · Dec 20, 2018

Track record of Viking Global Opportunities Illiquid Investments Sub-Master LP

Statistical track record

Free account

Open-market buys: 13

Last buy: Jan 11, 2022

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Viking Global Opportunities Illiquid Investments Sub-Master LP

Co-insiders of Viking Global Opportunities Illiquid Investments Sub-Master LP

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
BridgeBio Pharma, Inc.Listing on record	Jan 31, 2025	Sell	-3,065,616	34.90 USD	$107M	Unusual size	SEC
APi Group CorpListing on record	Mar 7, 2024	Sell	-60,772	34.25 USD	$2.1M		SEC
APi Group CorpListing on record	Mar 7, 2024	Sell	-2,977,845	34.25 USD	$102M	Unusual size	SEC
4D Molecular Therapeutics, Inc.Listing on record	Jan 5, 2024	Sell	-540,000	19.53 USD	$10.5M	Unusual size	SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-111,102	32.23 USD	$3.6M		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-52,466	32.23 USD	$1.7M		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-38,116	27.28 USD	$1M		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-3,142	31.44 USD	$98.8K		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-7,554	30.59 USD	$231.1K		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-75,096	29.14 USD	$2.2M		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-15,996	30.59 USD	$489.3K		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-156,463	30.90 USD	$4.8M	Unusual size	SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-80,715	27.28 USD	$2.2M		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-51,298	28.16 USD	$1.4M		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-73,886	30.90 USD	$2.3M		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-147,502	29.87 USD	$4.4M		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-6,654	31.44 USD	$209.2K		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-108,631	28.16 USD	$3.1M		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-159,026	29.14 USD	$4.6M		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-312,353	29.87 USD	$9.3M	Unusual size	SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Jan 13, 2022	Buy	2,300,000	19.00 USD	$43.7M	conv 73ClusterUnusual size	SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Jan 13, 2022	Other	4,870,536	—	n/a (No price was disclosed in the filing)		SEC
Rallybio CorpListing on record	Aug 2, 2021	Buy	806,000	13.00 USD	$10.5M	conv 36	SEC
Rallybio CorpListing on record	Aug 2, 2021	OtherD (derivative)	-21,578,387	—	n/a (No price was disclosed in the filing)		SEC
Rallybio CorpListing on record	Aug 2, 2021	Other	3,388,777	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
BridgeBio Pharma, Inc.Listing on record	Jan 31, 2025	Sell	-3,065,616	34.90 USD	$107M	Unusual size	SEC
APi Group CorpListing on record	Mar 7, 2024	Sell	-60,772	34.25 USD	$2.1M		SEC
APi Group CorpListing on record	Mar 7, 2024	Sell	-2,977,845	34.25 USD	$102M	Unusual size	SEC
4D Molecular Therapeutics, Inc.Listing on record	Jan 5, 2024	Sell	-540,000	19.53 USD	$10.5M	Unusual size	SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-111,102	32.23 USD	$3.6M		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-52,466	32.23 USD	$1.7M		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-38,116	27.28 USD	$1M		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-3,142	31.44 USD	$98.8K		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-7,554	30.59 USD	$231.1K		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-75,096	29.14 USD	$2.2M		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-15,996	30.59 USD	$489.3K		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-156,463	30.90 USD	$4.8M	Unusual size	SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-80,715	27.28 USD	$2.2M		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-51,298	28.16 USD	$1.4M		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-73,886	30.90 USD	$2.3M		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-147,502	29.87 USD	$4.4M		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-6,654	31.44 USD	$209.2K		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-108,631	28.16 USD	$3.1M		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-159,026	29.14 USD	$4.6M		SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Sep 9, 2022	Sell	-312,353	29.87 USD	$9.3M	Unusual size	SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Jan 13, 2022	Buy	2,300,000	19.00 USD	$43.7M	conv 73ClusterUnusual size	SEC
Amylyx Pharmaceuticals, Inc.Listing on record	Jan 13, 2022	Other	4,870,536	—	n/a (No price was disclosed in the filing)		SEC
Rallybio CorpListing on record	Aug 2, 2021	Buy	806,000	13.00 USD	$10.5M	conv 36	SEC
Rallybio CorpListing on record	Aug 2, 2021	OtherD (derivative)	-21,578,387	—	n/a (No price was disclosed in the filing)		SEC
Rallybio CorpListing on record	Aug 2, 2021	Other	3,388,777	—	n/a (No price was disclosed in the filing)		SEC